Today, we recognize #TripleNegativeBreastCancerDay. Triple negative breast cancer is a type of breast cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. If you have received a triple negative breast cancer diagnosis, you are not alone. We are here for you.
Triple-negative breast cancer is a difficult-to-treat cancer that affects 10-15% of breast cancer patients in the U.S., defined by the absence of 3 receptors: estrogen, progesterone, and HER2. Continued cancer research is essential to overcoming this challenge. #triplenegativebreastcancerday
On #TripleNegativeBreastCancerDay, we want to emphasize that ALL individuals with a TNBC diagnosis qualify for germline cancer genetic testing. Speak with your doctor/a genetic counselor to learn more. #genechat #precisionmedicine
